Opioid Antagonism in Individuals Ascertained Through the Partners HealthCare Biobank

Completed · Phase 1

Conditions studied: Reproductive Disorders

In brief

The goal of this study is to evaluate the effects of opioid antagonists on the hypothalamic-pituitary-gonadal axis in healthy subjects.

Key facts

Study ID

NCT04975347

Run by

Stephanie B. Seminara, MD

People needed

47

Starts

2022-06-03

Expected to finish

2025-08-08

Last updated by the study team

2026-02-18

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.